Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Accumulating evidence suggests that circular RNAs have the abilities to regulate gene expression during the progression of
sepsis
-associated acute kidney injury. Circular RNA
VMA21
(circVMA21), a recent identified circular RNA, could reduce apoptosis to alleviate intervertebral disc degeneration in rats and protect WI-38 cells from lipopolysaccharide-induced injury. However, the role of circVMA21 in
sepsis
-associated acute kidney injury (
sepsis
-associated AKI) is unknown. In this study, we first demonstrated that circVMA21 alleviated
sepsis
-associated AKI by reducing apoptosis and inflammation in rats and HK-2 cells. Additionally, to explore the molecule mechanism underlying the amelioration, after the bioinformatics analysis, we confirmed that miR-9-3p directly bound to circVMA21 by luciferase and RNA immunoprecipitation assay, and the effector protein of miR-9-3p was SMG1. Furthermore, the oxidative stress caused by
sepsis
-associated AKI was down-regulated by circVMA21. In conclusion, circVMA21 plays an important role in the regulating
sepsis
-associated AKI via adjusting miR-9-39/SMG1/inflammation axis and oxidative stress.
...
PMID:Circular RNA VMA21 ameliorates sepsis-associated acute kidney injury by regulating miR-9-3p/SMG1/inflammation axis and oxidative stress. 3282 42